FDA adcomm votes in favor of Pfizer's Covid-19 pill Paxlovid

The FDA’s Antimicrobial Drugs Advisory Committee voted 16-1 that the benefits of Pfizer’s Covid-19 pill Paxlovid outweigh the risks in adults with mild-to-moderate illness.